Reply to “Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US”
Open Access
- 14 February 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (2) , e14620
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the USAlzheimer's & Dementia, 2024
- Detecting Selection Bias in Observational Studies—When Interventions Work Too FastJAMA Internal Medicine, 2023
- The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's diseaseAlzheimer's & Dementia, 2022